EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Visualizing the epigenetic landscape of aging and cellular reprogramming – optimized ATAC-see for cells and tissues

Natalie J. Kirkland, Manuel A. Castro, Yihao Yang, Bhargav D. Sanketi, Mohammad Jaber, Veronica Lamas-Alverez, Freiya Malhotra, Juan Carlos Izpisua Belmonte, Pura Muñoz-Cánoves, Zachary A. Levine

Journal of Cell Science · 2026-11-01 · 139 (21)

DOI: 10.1242/jcs.264943 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Spatial chromatin organization dictates cellular function and resilience, yet scalable imaging methods to quantify chromatin states in situ across aging and interventions are lacking. Although ATAC-see can visualize accessible chromatin, its broader application is hindered by protocol variability, low throughput and incompatibility with complex tissues. Here, we systematically optimize the ATAC-see workflow for robust, high-throughput quantitative imaging in fixed, adherent mammalian cells and fresh frozen tissues. We validate the sensitivity of the platform to pharmacologic remodeling and apply it to replicative, chronological and pathological aging in primary human fibroblasts, revealing progressive age-associated chromatin opening and heterochromatin remodeling. Furthermore, we demonstrate that our optimized ATAC-see captures rapid, reversible chromatin reorganization during OSK(M)-driven partial reprogramming of aged fibroblasts. Finally, we extend a cost-effective and accessible protocol to murine tissue sections, quantifying in situ age-dependent remodeling. This standardized framework establishes chromatin accessibility as a highly scalable, sequencing-compatible imaging biomarker for evaluating aging and rejuvenation.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →